Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select international markets. The Company invests in life sciences venture capital funds whereby the Company may receive preferential access to healthcare products for Canada and select international markets. It develops pharmaceutical products, including those to treat neglected tropical and rare pediatric diseases. The portfolio consists of pharmaceutical products with molecules and includes both in-licensed products such as Lenvima, Cresemba, Halaven, Trelstar, Akynzeo, Ambisome, Minjuvi, Imvexxy as well as products owned by Knight such as Exelon and Impavido.


TSX:GUD - Post by User

Post by wofatson Sep 17, 2021 4:54pm
177 Views
Post# 33880095

So 6 earnings beats in a row will it be 7?

So 6 earnings beats in a row will it be 7?

I still must be missing something 

The last quarter earinings consensuss was for -.07  They earned .23,a .30 beat.
This quarter earning  consensus is for .02.  Last year they earned .14.  I expect 14+ for this quarter
For the full year earnings for 2020 were 31.76 million 
For the second quarter 2021 earnings were 29 million 
2019 EPS .10.    2020 EPS .32.  2021 EPS ? What this number is will make a difference 
Almost 50% of all the stock trades are done on other exchanges ( not the TSX )
It looks as though the growth investors are moving out and the value investers are moving in.

Paladin keeps being brought up.
From 1998 to 2008 the stock price bounced around like a rubber ball.Then they posted earning that made the market and the advisors take notice . Keep in mind Paladin had 21 million shares so any bounce was noticeable . 
 

WHAT AM I MISSING?

 

<< Previous
Bullboard Posts
Next >>